TransMedics Group, Inc. Debt Securities, Available-for-sale, Amortized Cost
TransMedics Group, Inc. (TMDX) had Debt Securities, Available-for-sale, Amortized Cost of $27.80 million as of 2022-06-30, per its 10-Q filed 2022-08-03.
Discontinued › Notes › Credit Losses
us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis · last filed 2023-02-27
- 2022-06-30: Debt Securities, Available-for-sale, Amortized Cost $27.80M.
- 2022-03-31: Debt Securities, Available-for-sale, Amortized Cost $54.21M.
- 2021-12-31: Debt Securities, Available-for-sale, Amortized Cost $66.91M.
- 2021-09-30: Debt Securities, Available-for-sale, Amortized Cost $80.36M.
| Period end | Debt Securities, Available-for-sale, Amortized Cost |
|---|---|
| 2022-06-30 | $27.80M 10-Q · filed 2022-08-03 |
| 2022-03-31 | $54.21M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $66.91M 10-K · filed 2023-02-27 |
| 2021-09-30 | $80.36M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $86.93M 10-Q · filed 2021-08-06 |
| 2021-03-31 | $91.37M 10-Q · filed 2021-05-07 |
| 2020-12-31 | $101.05M 10-K · filed 2022-03-01 |
| 2020-09-30 | $111.27M 10-Q · filed 2020-11-06 |
| 2020-06-30 | $88.11M 10-Q · filed 2020-08-07 |
| 2020-03-31 | $47.55M 10-Q · filed 2020-05-06 |
| 2019-12-28 | $60.54M 10-K · filed 2021-03-11 |
| 2019-09-28 | $67.81M 10-Q · filed 2019-11-08 |
| 2019-06-29 | $48.97M 10-Q · filed 2019-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |